These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27760048)

  • 21. Rtp801 suppression of epithelial mTORC1 augments endotoxin-induced lung inflammation.
    Nadon AM; Perez MJ; Hernandez-Saavedra D; Smith LP; Yang Y; Sanders LA; Gandjeva A; Chabon J; Koyanagi DE; Graham BB; Tuder RM; Schmidt EP
    Am J Pathol; 2014 Sep; 184(9):2382-9. PubMed ID: 25016184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger.
    Prevot N; Pyaram K; Bischoff E; Sen JM; Powell JD; Chang CH
    J Immunol; 2015 Jan; 194(1):223-30. PubMed ID: 25404366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cochaperone BAG3 coordinates protein synthesis and autophagy under mechanical strain through spatial regulation of mTORC1.
    Kathage B; Gehlert S; Ulbricht A; Lüdecke L; Tapia VE; Orfanos Z; Wenzel D; Bloch W; Volkmer R; Fleischmann BK; Fürst DO; Höhfeld J
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):62-75. PubMed ID: 27756573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine.
    Sutton LP; Caron MG
    Neuropharmacology; 2015 Dec; 99():610-9. PubMed ID: 26314207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition.
    Sun D; Liu H; Dai X; Zheng X; Yan J; Wei R; Fu X; Huang M; Shen A; Huang X; Ding J; Geng M
    Cancer Lett; 2017 Oct; 406():105-115. PubMed ID: 28687354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
    Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA
    Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models.
    Guan Y; Zhang L; Li X; Zhang X; Liu S; Gao N; Li L; Gao G; Wei G; Chen Z; Zheng Y; Ma X; Siwko S; Chen JL; Liu M; Li D
    J Immunol; 2015 Jul; 195(1):339-46. PubMed ID: 26026060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
    Mi W; Ye Q; Liu S; She QB
    Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function.
    Shin J; Wang S; Deng W; Wu J; Gao J; Zhong XP
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):E776-83. PubMed ID: 24516149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals.
    Kimura T; Nada S; Takegahara N; Okuno T; Nojima S; Kang S; Ito D; Morimoto K; Hosokawa T; Hayama Y; Mitsui Y; Sakurai N; Sarashina-Kida H; Nishide M; Maeda Y; Takamatsu H; Okuzaki D; Yamada M; Okada M; Kumanogoh A
    Nat Commun; 2016 Oct; 7():13130. PubMed ID: 27731330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia.
    Gao Y; Gao J; Li M; Zheng Y; Wang Y; Zhang H; Wang W; Chu Y; Wang X; Xu M; Cheng T; Ju Z; Yuan W
    J Hematol Oncol; 2016 Apr; 9():36. PubMed ID: 27071307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTORC1 is essential for leukemia propagation but not stem cell self-renewal.
    Hoshii T; Tadokoro Y; Naka K; Ooshio T; Muraguchi T; Sugiyama N; Soga T; Araki K; Yamamura K; Hirao A
    J Clin Invest; 2012 Jun; 122(6):2114-29. PubMed ID: 22622041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
    McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
    Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
    Yuan T; Rafizadeh S; Gorrepati KD; Lupse B; Oberholzer J; Maedler K; Ardestani A
    Diabetologia; 2017 Apr; 60(4):668-678. PubMed ID: 28004151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.
    Wang S; Amato KR; Song W; Youngblood V; Lee K; Boothby M; Brantley-Sieders DM; Chen J
    Mol Cell Biol; 2015 Apr; 35(7):1299-313. PubMed ID: 25582201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein synthesis in plasma cells is regulated by crosstalk between endoplasmic reticulum stress and mTOR signaling.
    Goldfinger M; Shmuel M; Benhamron S; Tirosh B
    Eur J Immunol; 2011 Feb; 41(2):491-502. PubMed ID: 21268018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamtor1 Is Critically Required for CD4
    Hosokawa T; Kimura T; Nada S; Okuno T; Ito D; Kang S; Nojima S; Yamashita K; Nakatani T; Hayama Y; Kato Y; Kinehara Y; Nishide M; Mikami N; Koyama S; Takamatsu H; Okuzaki D; Ohkura N; Sakaguchi S; Okada M; Kumanogoh A
    J Immunol; 2017 Sep; 199(6):2008-2019. PubMed ID: 28768723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.
    Ghosh AP; Marshall CB; Coric T; Shim EH; Kirkman R; Ballestas ME; Ikura M; Bjornsti MA; Sudarshan S
    Oncotarget; 2015 Jul; 6(20):17895-910. PubMed ID: 26255626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.